The effects of deregulated Raf activation on the growth and differentiation of hematopoietic cells were investigated. The cytokine-dependent murine myeloid FDC-P1 and human erythroleukemic TF-1 cell lines were transformed to grow in response to deregulated Raf expression in the absence of exogenous cytokines. The conditionally active Raf proteins were regulated by ␤-estradiol as cDNAs containing the Raf catalytic, but lacking negative-regulatory domains, were ligated to the hormone binding domain of the estrogen receptor (⌬Raf:ER). Continuous ⌬Raf expression prevented apoptosis in the absence of exogenous cytokines and altered the morphology of the FD/⌬Raf:ER cells as they grew in large aggregated masses (Ͼ100 cells) whereas the parental cytokinedependent FDC-P1 cells grew in smaller grape-like clusters (Ͻ10 cells). FD/⌬Raf-1:ER cells growing in response to Raf activation displayed decreased levels of the Mac-2 and Mac-3 molecules on their cell surface. In contrast, when these cells were cultured in IL-3, higher levels of these adhesion molecules were detected. Expression of activated Raf oncoproteins also abrogated cytokine dependency and prevented apoptosis of TF-1 cells. Moreover, the differentiation status of these Raf-responsive cells was more immature upon Raf activation as culture with the differentiation-inducing agent phorbol 12 myristate 13-acetate (PMA) and ␤-estradiol resulted in decreased levels of the CD11b and CD18 integrin molecules on the cell surface. In contrast when the Raf-responsive cells were induced to differentiate with PMA and GM-CSF, in the absence of ⌬Raf:ER activation, increased levels of the CD11b and CD18 molecules were detected. Retinoic acid (RA) inhibited 3 H-thymidine incorporation in response to GM-CSF. Interestingly, Raf activation counterbalanced the inhibition of DNA synthesis caused by RA but not PMA. Thus deregulated Raf expression can alter cytokine dependency, integrin expression and the stage of differentiation. These Raf-responsive cell lines will be useful in elucidating the roles of the MAP kinase cascade on hematopoietic cell differentiation and malignant transformation. Leukemia
Introduction
The proliferation and survival of many hematopoietic precursor cells is promoted by interleukin-3 (IL-3), granulocyte/ macrophage-colony stimulating factor (GM-CSF), stem cell factor (SCF) and flt-3 ligand (the ligand for the tyrosine kinase receptors flt-2 and flt-3).
1-8 FDC-P1 is an IL-3/GM-CSF-dependent cell line derived from the bone marrow of normal DBA/2 mice and is representative of early hematopoietic precursor cells. 7 FDC-P1 cells proliferate continuously in culture as long as either IL-3 or GM-CSF is provided but they are nontumorigenic upon injection into syngeneic or immuno- compromised mice. 7, 9, 10 Spontaneous factor-independent cells are rarely (Ͻ10 −7 ) recovered from the FDC-P1 line. 9, 10 The human TF-1 line is an IL-3/GM-CSF-dependent line derived from a patient with an erythroleukemia. TF-1 cells are multipotential as they can differentiate into more mature erythroid, monocytic or megakaryocytic cells depending upon the differentiation stimulus. 11 Phorbol esters will promote the differentiation of TF-1 cells into more mature macrophage-like cells. 11 Erythropoietin combined with hemin and delta-aminolevulinic acid will stimulate the differentiation into more mature erythroid cells. 11 This cell line has a low spontaneous frequency of conversion to factor independence and TF-1 cells do not normally form tumors after injection in immunocompromised mice. [11] [12] [13] [14] [15] [16] [17] Thus, these cell lines represent models for analysis of the effects of aberrant oncogene expression on human hematopoietic cell growth, differentiation and malignant transformation.
The loss of cytokine dependency by hematopoietic cells may be an important factor in the development of leukemias. IL-3 and GM-CSF exert their biological activity by binding to the IL-3 and GM-CSF receptors, respectively (IL-3R and GM-CSFR). [1] [2] [3] [4] [5] [6] 18 These receptors are comprised of a ligand-specific ␣-subunit, and a common ␤-subunit (␤ c ), which is essential for signal transduction. [1] [2] [3] [4] [5] [6] 18 The binding of these cytokines to their cognate receptors activates a Janus (Jak-2) protein tyrosine kinase which leads to the phosphorylation and dimerization of signal transducers and activators of transcription (STATs) that, in turn, regulate the expression of key genes involved in cell growth. 1, 18 Recently, it has been demonstrated by deletional analysis of the ␤ c chain, that the membrane proximal domain is responsible for induction of the Jak-STAT pathway whereas the membrane distal domain is necessary for stimulation of the Ras-Raf pathway. 19 These distinct domains also result in the activation of proliferation and differentiation specific genes. The c-myc proto-oncogene is regulated by the membrane proximal domain and has been associated with the initiation of DNA synthesis. In contrast, the c-jun and c-fos proto-oncogenes are regulated by the membrane distal domain of the ␤ c chain. 19, 20 This distal receptor domain is also involved in the regulation of apoptosis. 20 Ras activation by the distal domain of the ␤ c chain has been linked with the suppression of apoptosis. 1, 20 Activation of Jak-2 by IL-3 may occur by receptor aggregation resulting in the multimerization of associated Jak-2 proteins. 1, 21 A similar scenario occurs after GM-CSF receptor ligation by GM-CSF. In addition, after receptor ligation, the Shc protein becomes phosphorylated and forms a complex with the receptor. Shc then recruits the Grb2/Sos complex to the ␤ c chain, which subsequently results in Ras activation leading to stimulation of Raf and mobilization of the MAP (ERK) kinase cascade. 1, 21 This activation can further result in the indirect Leukemia or direct phosphorylation of transcription factors which in turn regulate gene expression. 1, 21 The mitogen-induced Ras-Raf signal transduction pathway transduces critical growth and differentiation signals in many cells. 1, 21 The raf gene is evolutionarily conserved as raf genes have been described in Drosophilia and C. elegans. 1, 21 There are three related raf genes in mammals: A-raf, B-raf and raf-1.
1, 21 Loss of Raf expression can have severe developmental consequences for the organism. [22] [23] [24] [25] [26] [27] [28] [29] The Raf proteins have been dissected into three different functional domains: CR1, CR2, and CR3. The CR1 region has the binding site for an activated Ras protein. 1, 21 The CR2 region negatively regulates the Raf kinase domain (CR3) which is located in the carboxyl terminal of Raf.
26-31 N-terminal-deleted forms of these Raf proteins result in constitutively activated oncoproteins which transform fibroblastic murine NIH-3T3 cells. [26] [27] [28] Certain virally encoded oncoproteins (v-Abl, v-Erb-B, vFms, v-Fps, v-Raf and v-Src), activated cellular oncoproteins (BCR-ABL, TEL-ABL, TEL-JAK), membrane growth factor receptors (epidermal growth factor receptor (EGF-R), insulinlike growth factor-1 receptor (IGF-1R), 1, [32] [33] [34] [35] and specific protein kinase C isoforms 35 can alter the cytokine dependency of certain murine and human hematopoietic cells. The efficiency by which these oncoproteins abrogate the cytokine dependency often depends on the particular cell line examined.
The effects of deregulated oncogene expression of cell surface proteins involved in differentiation and adhesive properties are not well understood. Deregulated oncogene expression may keep cytokine-independent hematopoietic cells in a proliferative state which prevents their adhesion to cellular matrixes which would normally promote their terminal differentiation and eventual death. In the following study, the effects of aberrant Raf expression on integrin and cell surface receptor expression were investigated to gain a better understanding of how deregulated expression of the MAP kinase cascade can alter the growth and differentiation properties of hematopoietic cells. Conditional Raf genes were introduced into murine and human hematopoietic cells. Raf was expressed as a fusion protein with the binding domain of the estrogen receptor, so that the introduced Raf would only be active in the presence of a ligand specific for the estrogen receptor (␤-estradiol, or the estrogen-receptor antagonist 4-OH Tamoxifen (4-HT)).
Materials and methods

Cell lines and growth factors
Cells were maintained in a humidified 5% CO 2 incubator with Dulbecco's modified Eagle's medium (DMEM) complemented with 5% fetal bovine serum (FBS; Atlanta Biologicals, Atlanta, GA, USA). The IL-3/GM-CSF-dependent murine myeloid FDC-P1 7 cell line was cultured in medium supplemented with 10% WEHI-3B(D − ) conditioned medium (WCM) as a source of IL-3. The human TF-1 line. 11, 36 was purchased from the ATCC (Rockville, MD, USA) and grown in DMEM containing 5% FBS supplemented with 1 ng/ml recombinant (r) GM-CSF (R& D Systems, Minneapolis, MN, USA). Raf-dependent cells were grown in DMEM +5% FBS containing either 1 M ␤-estradiol (Sigma, St Louis, MO, USA) or 500 nM 4-Hydroxy-tamofixen (4-HT) (Sigma). Phorbol 12-myristate 13-acetate (PMA), 13-cis and all-trans RA (ATRA) were purchased from Sigma and dissolved in either dimethyl sulfoxide (DMSO; Sigma) or ethanol.
H-thymidine incorporation assays
Ten thousand cells/well were seeded in 96-well flat bottom plates (Corning, Corning, NY, USA) in the presence of either different concentrations of cytokine (IL-3 or GM-CSF) or ␤-estradiol. In addition, some cells were cultured in the presence of either PMA or RA plus either cytokine or ␤-estradiol. Each condition was assayed in triplicate. After 3 days of culture, 10 l of [ 3 H]-thymidine (6.7 Ci/mmol, New England Nuclear (NEN), Boston, MA, USA) was added to each well, and the cells were harvested 5 h later with an automated Tomtec Mac II (Orange, NJ, USA) 96-well plate harvester and counted on a 1450 Microbeta plate counter (Wallac, Gaithersburg, MD, USA).
Retroviral infection of cells
The modified Raf-1 and A-Raf cDNA constructs are contained in G418 r (pLNCX) retroviral vectors. 26, 27 The pLNC⌬Raf-1:ER vector contains the catalytic domain of human Raf-1 (aa 305-648) fused to the human hormone binding (hb) domain of the estrogen receptor (ER). The ⌬Raf-1:ER chimeric protein requires ␤-estradiol for its activation. 26 The pLNC⌬A-Raf:ER retroviral vector encodes the catalytic domain of murine ARaf fused to the hbER inserted into the pLNCX vector. 27 The plasmids encoding the Raf retroviruses were generously provided by Dr Martin McMahon (UCSF, San Francisco, CA, USA).
Plasmid DNAs containing recombinant retroviruses were transfected into the retroviral packaging cell lines ⌿2 or PA317 with lipofectin (Life Technologies, Bethesda, MD, USA). Retroviruses were passed sequentially from one cell line to the other to amplify their titers as described. 9, 10, 12 FDC-P1 cells were infected with viral stocks as described. 9, 10, 12 TF-1 cells were infected with amphitropic stocks prepared from the PA317 cell line. 12 The nomenclature of the FDC-P1 cells is FD/⌬Raf-1:ER for cells infected with the ⌬Raf-1:ER virus. The nomenclature of the TF-1 cells is TF/⌬Raf-1:ER or TF/⌬A-Raf:ER for cells infected with the ⌬Raf-1:ER or ⌬A-Raf:ER viruses, respectively.
Isolation of DNAs for apoptosis assays
After the cells were pelleted by centrifugation, the pellets were resuspended in 500 l of lysis buffer (20 mM Tris-HCl, pH 7.4, 10 mM EDTA, 0.2% Triton X-100) and placed on ice for 10 min as previously described. 16, 29 The lysate was then centrifuged for 10 min at 14 000 g and the pellet was discarded. Ten l of 10 mg/ml protease K (Life Technologies) was added to the supernatant and the mixture was incubated overnight at room temperature. Then the solution was phenol extracted twice then chloroform extracted twice and the aqueous phase was saved each time. The nucleic acids were ethanol precipitated and subsequently resuspended in sterile H 2 O. The concentration of the nucleic acids was determined and 20 g was treated with 10 l of 1 mg/ml Rnase A (Sigma) for 20 min. The remaining DNA was electrophoresed in an agarose gel with TBE (1× =0.09 M Tris borate, 0.002 M EDTA) running buffer containing ethidum bromide and visualized under UV light.
FACS analysis for receptor and integrin expression
Indirect immunofluoresence was performed as described previously 5 19 
Determination of raf kinase activity
The cells were grown in phenol-red free DMEM (Life Technologies) containing charcoal-stripped FCS and indicated supplements. Immune complexes of ⌬Raf:ER proteins were prepared by incubating cell lysates with ␣-hbER Ab (SCB) and protein A-sepharose beads (Pharmacia, Piscataway, NJ, USA). Immune complexes were collected, washed in lysis buffer, and the activities of ⌬Raf:ER proteins were assessed by incubation for 30 min at 30°C in a reaction mix containing 25 mM Hepes (pH 7.4), 10 mM MgCl 2 , 1 mM DTT, 50 M ATP and 10 M ␥-32 P-ATP (3000 C1/mmol; NEN) with 12.5 g of purified recombinant enzymatically unactive GST-MEK1 (Upstate Biotechnology (UBI), Lake Placid NY, USA) as a substrate as described previously. 14, [26] [27] [28] [29] [30] The reactions were analyzed by SDS-polyacrylamide gel electrophoresis and electrotransference to polyvinylidene difluoride membranes (PVDF, Immunobilon P; Millipore, Medford, MA, USA). Western blots were first exposed to X-ray film to quantitate GST-MEK1 phosphorylation and subsequently probed with an ␣-hbER Ab to quantitate the amount of the ⌬Raf:ER protein in each immunoprecipitate.
Determination of MEK activity
Aliquots from unfractionated cell lysates containing 60 g of total protein were incubated for 30 min at 30°C in a reaction mix containing 40 mM Hepes, pH 7.8, 10 mM MgCl 2 , 1 mM DTT and 40 M ATP and 2 g of bacterially expressed rp42, which is an enzymatically inactive form of the p42 MAP kinase. The reaction mixtures were electrophoresed through a 10% SDS-polyacrylamide gel. Tyrosine phosphorylation of Leukemia rp42 was examined by probing the Western blot with 4G10-hrp (UBI), a horseradish peroxidase-conjugated ␣-phosphotyrosine MoAb.
Determination of p42/44
MAPK activity
Cells were deprived of ␤-estradiol for 24 h in phenol-red free medium that contained 5% charcoal-stripped FCS. Then the cells were pulsed with cytokine or ␤-estradiol. Extracts were prepared, and the reactions were analyzed on SDS polyacrylamide gels. Western blots were probed with an antiserum (Promega, Madison, WI, USA) which recognizes the activated phosphorylated forms of MAP kinase (ERK1 and ERK2).
Polymerase chain reaction amplification of cytokine mRNA transcripts
Total cytoplasmic RNA was prepared as described 12,14-16 and 1 g was included in a 20 l cDNA synthesis reaction containing reverse transcriptase buffer, 1 mM of each dNTP, 20 mg/ml oligo-dT and 20 units Mo-MuLV reverse transcriptase. After incubation at 42°C for 40 min, the reaction was terminated by the addition of H 2 O. For PCR amplification, 5 l cDNA was included in a 50 l reaction mixture containing PCR buffer, dNTPs, 1-2 units Taq polymerase and 1 mM of each oligonucleotide primer. The primers for human GM-CSF were: CCTGGACTGGCTCCCAGCAG and GATGTG GCTGCAGAGCCTGC defining a 425 bp fragment. The primers for human ␤-actin were: GAGAAGAGCTAT GAGCTGCCT and TTCTGCATCCTGTCAGCAATG defining a 236 bp fragment. The primers for human IL-3 were CTCCTGCCGATCCAAACATGAG and AGAGGTTTCAGAA GTTCTGCTG defining a 575 bp fragment. Thirty-five cycles of PCR were performed to detect the cDNAs as described. 12, [14] [15] [16] The PCR products were electrophoresed on 1% agarose gels and visualized after ethidium bromide staining of the gel.
Results
Raf-responsive hematopoietic cells
The cytokine-dependent murine myeloid FDC-P1 and human erythroleukemic TF-1 cell lines were infected with the ⌬Raf-1:ER containing retrovirus. Raf-responsive cells were recovered by plating the cells in medium which contained ␤-estradiol and the selective drug G418 but lacked exogenous cytokines. Clones (c) and pools of cells were recovered during the isolation conditions. The objectives of the following studies were to determine the effects of activated Raf expression on proliferation, prevention of apoptosis and the levels of certain cell surface receptors in the conditionally transformed cells. . This Raf assay was performed on ␣ER precipitated proteins and detects activity induced by the ⌬Raf:ER proteins. This immunoprecipitation protocol does not detect the endogenous Raf kinase as only the ⌬Raf:ER proteins were included in the in vitro kinase assay. As a control for analyzing the amount of ⌬Raf:ER protein included in the Raf assays, the levels of the ⌬Raf:ER proteins used in the Raf kinase assay were examined by probing the Raf kinase blot with the ␣ER Ab (panel b). Relatively equal levels of ⌬Raf:ER proteins were detected.
␤-Estradiol induces Raf and downstream MEK and MAP kinase activities in FD/⌬Raf:ER cells
The levels of MEK activity were determined following treatment of the cells with IL-3, ␤-estradiol or not treated for 24 h (panel c). ␤-Estradiol also induced downstream MEK activity (panel c). An increase in MEK activity was not detected in the cells treated with IL-3 for 24 h. However, when the cells were deprived of ␤-estradiol and then treated with either IL-3 or ␤- estradiol for 1 h, increased levels of MEK activity were detected (data not presented). The presence of activated ERK1,2 was determined after the cells had been deprived of ␤-estradiol for 24 h and then treated with DMSO, IL-3, ␤-estradiol or PMA for 15 min. DMSO was used as a negative control as it is the vehicle for PMA. Treatment of the cells with DMSO did not lead to the detection of activated forms of ERK1 or ERK2. Similar results were observed when ethanol was used as a negative control (data not presented). PMA was used as a positive control as it is a strong inducer of ERK1,2 activation in these cells. ␤-Estradiol and IL-3 induced phosphorylation of ERK1 & ERK2 (Panel D). Thus, the downstream targets (MEK and ERK1,2) of Raf were induced by the ␤-estradiol stimulation of the ⌬Raf:ER kinase activity in Raf-responsive FD/⌬Raf-1:ER cells.
⌬Raf:ER induces Raf-responsive growth in FDC-P1 cells
To determine the effects of the introduced conditionally active Raf-1 kinase, the growth properties of the Raf-responsive FD/⌬Raf-1:ER and the parental IL-3-dependent FDC-P1 cells were compared. 
Activated Raf prevents apoptosis in FD/⌬Raf:ER cells
To determine whether activated Raf would prevent apoptosis in the Raf-responsive ⌬Raf-1:ER-infected cells, the cells were cultured in the presence and absence of IL-3 or ␤-estradiol for various periods of time. Apoptosis was measured by the presence of a DNA fragmentation ladder. An apoptotic DNA fragmentation ladder is a characteristic of apoptosis and occurs due to degradation of chromatin into a ladder of approximately 180 bp repeat fragments due to nucleosome positioning. Low molecular weight DNAs were isolated from the Raf-responsive ⌬Raf:ER-infected and cytokine-dependent FDC-P1 cells (Figure 3) . When the FD/⌬Raf-1:ER cells were cultured in the absence of IL-3 and ␤-estradiol they underwent To determine whether Raf altered the expression of the cFms, IL-3R␣, IL-3R␤, Mac-2 and Mac-3 molecules, the Rafresponsive FD/⌬Raf-1:ER(Est)c2 cells were grown in medium containing IL-3 or ␤-estradiol and FACS analysis was perfor- exogenous IL-3 led to a decrease in the levels of Mac-2 and Mac-3 differentiation antigens detected on the cell surface. Alternatively, factors in addition to Raf are needed to maintain the expression of these differentiation markers.
To determine whether Raf affected the expression of the cytokine receptors necessary for normal cell growth and survival of these cells, the expression of the IL-3 receptor (␣ and ␤ chains) was examined ( Figure 6 ). The effects of Raf on the IL-3 receptor expression were examined since constitutive Raf expression could potentially down regulate cytokine receptor expression. The Raf-responsive FD/⌬Raf-1:ER(Est)c2 cells expressed high levels of the IL-3 receptor ␣ chain when they were grown in either IL-3 (panel b) or ␤-estradiol (panel e). Moreover, the FD/⌬Raf-1:ER cells expressed the ␤c and ␤ IL3 chains when the cells were grown in the presence of either IL-3 or ␤-estradiol. The expression of the GM-CSFR␣ chain also did not vary significantly when the FD/⌬Raf-1(Est)c2 cells were cultured in either IL-3 or ␤-estradiol (data not presented). Thus, the expression of the cytokine-receptor chains, in contrast to the Mac-2 and Mac-3 molecules, was not significantly altered by growth in response to Raf.
Effects of activated Raf expression on the cytokine dependency of human hematopoietic TF-1 cells
To further establish the model for the effects of aberrant Raf expression on cell growth and differentiation, the ability of deregulated Raf to abrogate the cytokine dependency and differentiation capacity of human hematopoietic TF-1 cell line Leukemia was examined. In the initial experiments, it was observed that ⌬Raf-1:ER-infected cells recovered from the 96-well plate and expanded into a 10 ml culture did not readily incorporate A-Raf has been reported recently to be able to stimulate certain proliferative responses in hematopoietic cells better than Raf-1. 38 Given the poor growth characteristics of the initial pool of TF/⌬Raf-1:ER(Est) cells, we examined whether there was a difference in the abilities of the activated ⌬Raf-1:ER and ⌬A-Raf:ER to relieve the cytokine dependency of human hematopoietic cells. In contrast to the results observed after infection with the ⌬Raf-1:ER virus, the initial pool of ⌬A-Raf:ER-infected cells incorporated [ infected TF-1 cells were recovered after limiting dilution analysis of the TF/⌬A-Raf:ER(Est)pool-1 in medium containing ␤-estradiol. All four of these clones proliferated in response to ⌬A-Raf:ER activation. An example is the TF/⌬A-Raf:ER(Est)c4 clone which incorporated much more [ 3 H]-thymidine in response to ␤-estradiol (panel h) than to GM-CSF (panel g). Interestingly, the TF/⌬A-Raf:ER(Est) cells incorporated 3 H-thymidine at 10-fold lower levels of ␤-estradiol than the Rafresponsive TF/⌬Raf-1:ER(Est)Pool-2 cells (0.5 vs 5 nM, respectively). In addition, the TF/⌬A-Raf:ER(Est) cells displayed a reduced sensitivity to rGM-CSF in these assay conditions.
To determine whether the Raf-responsive TF/⌬Raf-1:ER and TF/⌬A-Raf:ER cells would proliferate in medium containing ␤-estradiol, their growth was measured in medium containing either GM-CSF or ␤-estradiol (Figure 8 ). TF/⌬Raf-1:ER(Est) cells which had been maintained in ␤-estradiol for over 1 month grew in response to Raf-1 activation (panel a). Likewise, the TF/⌬A-Raf:ER(Est) cells proliferated in ␤-estradiolcontaining medium (panel b). Importantly, the growth of both cell lines was conditional as they did not proliferate in the absence of GM-CSF or ␤-estradiol. Interestingly, the TF/⌬A-Raf:ER cells initially proliferated to a greater extent in medium supplemented with ␤-estradiol than GM-CSF.
To determine whether there was an autocrine component to the growth of the Raf-responsive cells, the parental TF-1 line was cultured in different concentrations of supernatants prepared from the Raf-responsive cells (Figure 9 
Activated Raf induces downstream kinase activity in ⌬Raf:ER-infected TF-1 cells
To determine whether ␤-estradiol induced the Raf/MEK/MAP kinase pathway in the infected TF-1 cells, Raf and downstream kinase assays were performed (Figure 10 ). ␤-Estradiol induced Raf kinase activity in both ⌬A-Raf:ER (panel a) and ⌬Raf-1:ER (panel e) infected cells. However, the level of Raf kinase activity in the TF/⌬A-Raf:ER(Est) cells was significantly lower than in the TF/⌬Raf-1:ER(Est) cells. These results are consistent with the observation that A-Raf is a weaker kinase than Raf-1. 14, 16, [27] [28] [29] As a control to determine the levels of ⌬Raf:ER proteins immunoprecipitated and used in the kinase assays, the Raf kinase blots were probed with the ␣ER Ab (panels b and f). Relatively equal levels of ⌬Raf:ER proteins were detected in the protein extracts prepared from the cells grown under the different conditions. Thus, the lower level of Raf kinase activity detected in TF/⌬A-Raf:ER cells was not due to less ⌬A-Raf:ER protein immunoprecipitated.
To determine whether ⌬A-Raf:ER or ⌬Raf-1:ER induced the downstream signaling molecules, the appropriate kinase assays were performed. ⌬A-Raf:ER and ⌬Raf-1:ER also induced MEK activity in the Raf-responsive cells (panels c and g). Moreover, activated forms of MAPK kinase (ERK1 and ERK2) were detected in the Raf-responsive ⌬A-Raf:ER and ⌬Raf-1:ER cells treated with either GM-CSF or ␤-estradiol (panels d and h). The activation specific anti-phospho-ERK antibody usually recognizes more activated ERK2 in these cells. That is why the activated ERK2 is usually darker than
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Figure 8
Growth the activated ERK1 band. PMA usually induced higher levels of ERK1 and ERK2 activation than GM-CSF. In contrast, ␤-estradiol did not induce Raf or MEK activity or activated forms of ERK1 and ERK2 in uninfected TF-1 cells (data not shown).
Activated Raf prevents apoptosis in TF-1 cells
The effects of the ⌬A-Raf:ER oncoprotein on apoptosis in the TF/⌬A-Raf:ER(Est)Pool were examined and compared to the cytokine-dependent parental cell line (Figure 11 ). Uninfected TF-1 cells underwent apoptosis after culture for 24 h in the absence of GM-CSF (lane 1). However, when these cells were cultured in GM-CSF, they did not undergo apoptosis (lane 2). Culture of uninfected TF-1 cells in ␤-estradiol, in the absence of GM-CSF, did not prevent apoptosis as an apoptotic DNA ladder was visible (lane 3).
Culture of the Raf-responsive TF/⌬A-Raf:ER(Est)Pool in the absence of GM-CSF and ␤-estradiol for the first 24 h (lane 4) did not result in apoptosis. Apoptosis became detectable in the Raf-responsive cells when they were deprived of 
␤-estradiol for 2 days (lane 7) and more pronounced after 3 days (lane 10).
Apoptosis was prevented by GM-CSF in the Raf-responsive TF/⌬A-Raf:ER(Est) Pool for the first 2 days (lanes 5 and 8) . However, after 3 days of culture of these cells in GM-CSF, a DNA ladder was readily visible (lane 11). In contrast, when the TF/⌬A-Raf:ER(Est) pool was maintained in ␤-estradiol for these time periods they did not undergo apoptosis (lanes 6, 9 and 12). Thus, the ⌬A-Raf:ER oncoprotein blocked the induction of apoptosis normally induced by cytokine deprivation.
Effects of the Raf oncoproteins on the induction of differentiation
As controls, the effects of PMA and RA were examined on the parental TF-1 cells (Figure 12, panels a and b) . TF-1 cells are exquisitely sensitive to the effects of PMA, as doses of PMA greater than 0.5 nM totally suppressed ␤-Estradiol induces RAF and downstream kinases in TF/⌬Raf:ER cells. Protein extracts were prepared from Raf-responsive TF/⌬Raf-1:ER(Est)c2 and TF/⌬A-Raf:ER(Est)c4 cells either cultured for 24 h in the presence of no growth supplement (none), 1000 pg/ml GM-CSF or 1 M ␤-estradiol and then Raf kinase assays (panels a and e) and MEK assays (panels c and g) were performed. The levels of ⌬Raf:ER proteins immunoprecipitated in the Raf kinase assays were determined by probing the Raf kinase blots with an ␣ER Ab (panels b and f). For the ERK1, ERK2 activation, the cells were incubated in the absence of ␤-estradiol for 24 h and then treated with either 1000 pg/ml GM-CSF, 1 M ␤-estradiol or the negative control 0.1% DMSO or the positive control 10 nM PMA for 15 min (panels d and h).
To determine the effects of ATRA on DNA synthesis in Rafresponsive TF/⌬A-Raf:ER and TF/⌬Raf-1:ER cells, they were treated with 5 M ATRA acid in the presence and absence of either GM-CSF or ␤-estradiol and the extent of (panel g, lane 6 ). Thus, expression of an activated Raf gene inhibited the ability of ATRA but not PMA to induce a state of growth arrest in these cells. This suggests that a pathway of differentiation, which is induced by ATRA and leads to the suppression of DNA synthesis, is inhibited by the activated Raf oncoproteins.
Raf suppresses morphological changes induced by ATRA but not phorbol esters
To determine whether Raf would also block morphological changes associated with differentiation into more terminally
Figure 11
Prevention of apoptosis in Raf-responsive TF/⌬A-RaF:ER(EST) pool. Low molecular weight DNAs were recovered from the cells grown under the indicated conditions for the designated periods of time. The cells were grown in medium containing: 1000 pg/ml GM-CSF, 1 M ␤-estradiol or no supplement. YY indicates the presence of wild-type tyrosine residues at the phosphorylation domain.
committed cells, the Raf-responsive TF/⌬A-Raf:ER cells were cultured in the presence of PMA and ATRA ( Figure 13 ). When the cells were cultured in the absence of cytokines for 3 days, the presence of fragmented apoptotic cells was visible. In contrast, when the cells were cultured with GM-CSF (GM), ␤-estradiol (Est) or the combination of GM-CSF + ␤-estradiol, very few apoptotic cells were visible. PMA induced the differentiation of these cells, as when they were cultured with PMA in the presence and absence of GM-CSF, the cells became more adherent and there was often the presence of large cells with pseudopodia. In contrast, when the cells were cultured in Est + PMA the cells were not as morphologically differentiated as when the cells were cultured in GM-CSF + PMA although these cells were not proliferating.
Culture of the cells in GM-CSF + ATRA also resulted in morphological maturation of the cells, however, the cells were not as adherent and elongated as when they were treated with PMA. When the cells were cultured in ␤-estradiol and ATRA, the presence of the apoptotic cells was no longer visible. Thus, activated Raf hindered the differentiation of the TF/⌬Raf-1:ER cells in response to RA. Similar results were observed in the Raf-responsive TF/⌬A-Raf:ER(Est) cells.
Raf blocks certain aspects of differentiation of TF/⌬A-Raf:ER cells into more macrophage-like cells
To further examine the effects of the ⌬A-Raf:ER oncogene on the differentiation capacity of the TF-1 cells, the expression of certain cell surface adhesion molecules was monitored by flow cytometric analysis. The cells were either cultured in the presence of ␤-estradiol or GM-CSF and in some cases the cells were also exposed to PMA which exerted the most dramatic effects on differentiation as shown previously in Figures 12  and 13 . Increased expression of the CD11b and CD11c integrins has been associated with myeloid differentiation, whereas CD11a is often detected on earlier precursor cells. [38] [39] [40] [41] [42] When the cells were cultured in GM-CSF or ␤-estradiol, they expressed a low level of the CD11b integrin ( Figure 14,  panel a) .
When the Raf-responsive TF/⌬A-Raf:ER cells were cultured in the presence of GM-CSF + PMA, an increase in CD11b expression was observed (panel b). In contrast, when the cells were cultured with ␤-estradiol and PMA, a similar increase in CD11b expression was not observed (panel b). The lack of CD11b expression was not due to an absence of exogenous GM-CSF in the medium since when the TF/⌬A-Raf:ER cells were cultured in ␤-estradiol and PMA they synthesized GM-CSF (data not presented). Therefore, the activated A-Raf oncoprotein hindered the expression of the differentiationassociated CD11b chain.
As controls for the effects of ␤-estradiol on gene expression, the expression of these molecules were examined in uninfected TF-1 cells. ␤-Estradiol did not inhibit the expression of the CD11b, CD11c, CD11a and CD18 molecules in TF-1 cells treated with either (GM-CSF + ␤-estradiol) or (GM-CSF + ␤-estradiol + PMA) (data not presented). Moreover, similar results were obtained when the cells were treated with 4-HT in place of ␤-estradiol (data not presented). Therefore, the lack of increased CD11b expression was not due to a non-specific effect on differentiation elicited by ␤-estradiol.
The expression of the CD11a and CD11c integrins was also examined. CD11a and CD11c were detected at decreased levels in TF/⌬A-Raf:ER-transformed cells cultured in ␤-estradiol as compared to GM-CSF (panels c and e, respectively). The lower levels of expression of the CD11c chain observed when the cells were grown in ␤-estradiol, suggested that ⌬A-Raf:ER expression resulted in a more immature state.
The expression of these integrins did not differ when the cells were cultured in PMA and either ␤-estradiol or GM-CSF (panels d and f), indicating that the regulation of the CD11b gene differed from the CD11a and CD11c genes. These results are consistent with the hypothesis that constitutive ⌬A-Raf:ER expression results in the blockage of a particular aspects of differentiation, which involves the expression of CD11b.
As a control, the levels of background fluorescence were determined in the cells grown in either GM-CSF or ␤-estradiol in the presence and absence of phorbol esters ( Figure 15 ). These cells showed similar levels of background fluorescence when they were cultured in either GM-CSF or ␤-estradiol (panel A). Slightly higher levels of background fluorescence were observed when the cells were cultured in medium containing PMA and either GM-CSF or PMA (panel B).
The effects of ⌬A-Raf:ER expression on the expression of the CD18 integrin were also examined (panels c and d). CD18 is the ␤-chain which pairs with an ␣ chain (CD11a, CD11b or CD11c) and results in the formation of different functional integrin receptors. The expression of the CD18 molecule was higher in the cells grown in GM-CSF as opposed to ␤-estradiol Effects of differentiation inducing agents on 3 H-thymidine incorporation in RAF-responsive TF/⌬Raf:ER cells. Cells were treated in the indicated conditions for 3 days and then 3 H-thymidine incorporation was measured. (Panels a, b and c) TF-1 cells; (panels d and e) TF/⌬A-Raf:ER(Est) c4; and (panels f and g) TF/⌬Raf-1:ER(Est)c2. In panels a, b and c the GM-CSF concentration in the medium was constant at 1000 pg/ml. In panels d, e, f and g, the concentrations of PMA =10 nM, GM-CSF =1000 pg/ml, ␤-estradiol =1 M and ATRA =5 M. The experiments presented in panels d and f were performed on different days from those presented in panels e and g. That is the reason the responses to ␤-estradiol are slightly different. 
Expression of the GM-CSFR␤ chain in TF/⌬A-Raf:ER cells
As an additional specificity control, the effects of Raf on the expression of the GM-CSFR-␤ chain were examined ( Figure  16 expressed the GM-CSFR␤ chain. In fact, the cells expressed more GM-CSFR␤ chains on the cell surface when they were treated with phorbol esters and ␤-estradiol, than with phorbol esters and GM-CSF (panel f). Thus, unlike the CD11b and CD11c integrin molecules, the GM-CSFR␤ c chains were expressed when ⌬A-Raf:ER was activated and the intensity of GM-CSFR␤ c expression was not reduced when the cells were induced to further differentiate along the monocytic pathway with PMA.
Discussion
These studies were undertaken to determine how the expression of the Raf oncoproteins could alter the growth and differentiation capacity of murine and hematopoietic cells. Knowledge of how aberrant oncogene expression influences hematopoietic cell growth and differentiation will potentially increase our ability to treat certain leukemia patients. The activated Raf oncoproteins promoted growth, prevented apoptosis and altered differentiation in the Raf-responsive FD/⌬Raf-1:ER, TF/⌬Raf-1:ER and TF/⌬A-Raf:ER cells.
Raf-responsive FD/⌬Raf-1:ER cells were recovered directly after infection and selection in medium containing G-418 and IL-3. The effects of the activated ⌬Raf:ER oncoproteins were direct as the estrogen-receptor antagonist 4-HT also supported growth. Moreover, ␤-estradiol induced Raf and downstream MEK and MAP kinase activation. These activated Raf oncoproteins also prevented apoptosis when the cells were grown in the absence of exogenous cytokines. The effects of the activated Raf oncoproteins were conditional as, upon removal of ␤-estradiol, Raf activity decreased and the cells underwent apoptosis.
When murine FD/⌬Raf:ER cells were induced to grow in response to Raf activation, they often grew as clumps of cells. This may indicate that they grew more efficiently when there was cell to cell contact. Indeed, we have determined that these cells synthesize GM-CSF which may explain why their growth was also density dependent, another hallmark of autocrine transformation. 42 The expression of the Mac-2 and Mac-3 molecules, which are macrophage differentiation markers, were detected at decreased levels in the FD/⌬Raf-1:ER cells when they grew in response to Raf activation. In contrast, the expression of the Mac-2 and Mac-3 molecules increased when the cells were cultured in exogenous IL-3. The expression of the 110 kDa Mac-3 glycoprotein normally increases during differentiation of monocytes into activated peritoneal macrophages. 43, 44 These results support the hypothesis that Raf is blocking certain pathways of macrophage differentiation in FD/⌬Raf-1:ER cells. Alternatively, optimal expression of these molecules requires a signaling component induced by IL-3.
The effects of Raf on the expression of cell surface molecules was specific, as growth of the FD/⌬Raf:ER cells in response to Raf activation, in the absence of exogenous IL-3, did not result in a change in the expression of the IL-3R␣, IL-3␤ c , or c-Fms receptor chains. Even though the cells grew in response to Raf activation there remained a requirement for autocrine GM-CSF-mediated signal transduction and growth. This may be the reason why they continued to express the IL-3R␤ c (= GM-CSFR␤ c ) chain. Thus, both the Raf and cytokinemediated signal transduction pathways may serve important independent as well as overlapping roles in the growth of these cells.
Studies performed with an activated ⌬Raf-1 gene without the estrogen-receptor domain also indicate that ⌬Raf-1 can abrogate the cytokine dependency of hematopoietic cells. 29, 30 These cells form tumors upon injection into immunocompromised mice. Thus, aberrant expression of Raf can result in the malignant transformation of FDC-P1 cells. Further experiments are in progress to understand how Raf alters signal Leukemia transduction pathways and results in neoplastic transformation. Studies are being performed in our laboratory to determine whether activated Raf modifies the expression of certain apoptotic regulatory molecules, as well as, cell cycle regulatory molecules. The effects of activated Raf on the abrogation of cytokine dependency were not limited to murine FDC-P1 cells as activated Raf also abrogated the cytokine dependency of human hematopoietic TF-1 cells. ␤-Estradiol induced Raf and downstream MEK and MAPK activity in Raf-responsive TF-1 cells. Activated Raf also prevented apoptosis in these cells. Interestingly, the Raf-responsive TF-1 cells also synthesized autocrine cytokines. The initial inability of the TF/⌬Raf-1:ER (Est)Pool-1 to grow robustly in response to ␤-estradiol may have been due to the lack of significant autocrine GM-CSF production. Once the cells had acquired the ability to synthesize GM-CSF, they grew more robustly in response to ␤-estradiol. The Raf-responsive ⌬A-Raf:ER cells which had been cultured in ␤-estradiol incorporated higher levels of [ 3 H]-thymidine and proliferated better in response to ␤-estradiol than GM-CSF. This may be due to the ability of ⌬A-Raf:ER to efficiently induce a signal transduction cascade, in addition to a pathway stimulated by GM-CSF, which promotes proliferation. The ⌬A-Raf:ER cells were adapted to grow in response to both cascades and when they were shifted to GM-CSF, in the absence of ␤-estradiol, their growth was initially sluggish since they lacked this additional pathway induced by ⌬A-Raf:ER.
Interestingly, our studies have indicated that activation of Raf, as well as downregulation of protein kinase C (PKC), influence human hematopoietic cell growth and differentiation. Raf can induce proliferation and inhibit some aspects of differentiation in ⌬Raf:ER-transformed TF-1 cells. PKC downregulation after prolonged treatment with PMA resulted in differentiation and inhibition of TF/⌬Raf:ER cell proliferation. Since PKC is a Raf activator, 14 it is consistent to observe opposite results after Raf activation and prolonged PMA treatment, as in the absence of functional PKC, Raf may not be fully activated.
ATRA also induced a cessation of [ 3 H]-thymidine incorporation that was more pronounced when the cells were treated with GM-CSF than with ␤-estradiol. When the cells were treated with ATRA and ␤-estradiol, no significant decrease in [ 3 H]-thymidine incorporation was observed, which is consistent with a blockade of RA-induced differentiation by activated ⌬A-Raf:ER. Further studies are necessary to determine how Raf inhibits certain aspects of differentiation in hematopoietic cells. It is not simply that the cells do not differentiate in the absence of GM-CSF as when the cells are cultured in ␤-estradiol they synthesize sufficient autocrine/paracrine GM-CSF to promote growth. Moreover, both Raf and GM-CSF activate downstream MEK, ERK and p90
Rsk molecules which further activate transcription factors that control gene expression. The Raf kinase cascade could modulate the post-translational modification of certain transcription factors (eg, ETS, PU-1) which bind to the promoter regions of certain integrins and repress their synthesis. [40] [41] [42] Alternatively, Raf may induce the expression of a different panel of genes which is incompatible with the expression of differentiation-related genes.
These cells provide a source to study the effects of a critical oncogene involved in a central signal transduction pathway. In addition, these cells provide a model to investigate the abilities of drugs which target Raf and the downstream MEK/ERK kinase cascade to alter their activity and promote terminal differentiation of leukemic cells. These cell lines will be useful in investigating the mechanisms by which the Rafmediated signal transduction cascade alters the growth and differentiation capacity of hematopoietic cells.
